Sex‐Related Differences in the Prognostic Role of Acetylcholine Provocation Testing
Journal of the American Heart Association · 04.03.2025 · 14 (5)
DOI: 10.1161/jaha.124.037942 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 04.03.2025. Verfasst von Riccardo Rinaldi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Pulmonary Sciences Catholic University of the Sacred Heart Rome Italy. Hauptthemen laut MEDLINE: Acetylcholine, Myocardial Infarction, Coronary Vasospasm, Angina Pectoris. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Intracoronary provocation testing with acetylcholine (ACh) is helpful to diagnose and risk‐stratify patients with ischemia with nonobstructed coronary arteries (NOCA) and myocardial infarction with NOCA. This study explored potential sex‐related disparities on the prognostic significance of ACh provocative testing.
Methods
Consecutive patients with ischemia with NOCA and those with myocardial infarction with NOCA who underwent ACh provocation testing were enrolled. The primary end point was the incidence of major adverse cardiovascular and cerebrovascular events at follow‐up. Co‐primary end points were angina recurrence and quality of life assessed by 12‐month Seattle Angina Questionnaire (SAQ) summary score.
Results
A total of 519 patients (mean age, 61.4±12.1 years; 275 [53.0%] women and 244 [47%] men) were enrolled: 346 (66.7%) with ischemia with NOCA and 173 (33.3%) with myocardial infarction with NOCA. A positive ACh test was observed in 274 (52.8%) patients, with a lower prevalence of epicardial spasm (82 [56.2%] versus 106 [82.8%]) and a higher prevalence of microvascular spasm (64 [43.8%] versus 22 [17.2%]) in women compared with men ( P >0.001). After a median 22‐month follow‐up, major adverse cardiovascular and cerebrovascular events occurred in 53 (10.2%) patients, without significant sex differences ( P >0.05). Men with a positive ACh test had a significantly higher rate of major adverse cardiovascular and cerebrovascular events (22 [17.2%] versus 5 [4.3%], P =0.002) compared with those with a negative test; no difference was observed in women ( P >0.05) ( P for interaction=0.003). Women with a positive test experienced a higher rate of angina recurrence (61 [41.8%] versus 32 [24.8%], P =0.005) and a lower SAQ summary score (82 [interquartile range, 72–90] versus 86 [interquartile range, 78–100], P 0.05).
Conclusions
This study revealed the importance of recognizing sex‐specific differences in the prognostic value of ACh testing for proper management of coronary vasomotor disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular and Pulmonary Sciences Catholic University of the Sacred Heart Rome Italy.
- Cardiology Unit Infermi Hospital Rimini Italy.
- Department of Cardiology S. Maria dei Battuti Hospital, AULSS 2 Veneto Conegliano TV Italy.
- Hospital Clínic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.
- Division of Cardiology Azienda Ospedaliero Universitaria Policlinico "G. Rodolico-San Marco", University of Catania Catania Italy.
- Division of Cardiology University of Parma, Parma University Hospital Parma Italy.
ORCID-Profile: Riccardo Rinaldi, Michele Russo, Giovanni Occhipinti, Claudio Laudani, Ilaria Torre, Michele Colucci, Francesco Maria Animati, Giovanna Liuzzo, Tommaso Sanna, Antonio Maria Leone, Gaetano A Lanza, Carlo Trani, Francesco Burzotta, Filippo Crea, Rocco A Montone
Zitieren
APA
Rinaldi, R., Russo, M., Occhipinti, G., Laudani, C., Torre, I., Colucci, M., Gurgoglione, F. L., Animati, F. M., Lenkowicz, J., Tudor, A. M., Liuzzo, G., Sanna, T., Leone, A. M., Niccoli, G., Lanza, G. A., Trani, C., Burzotta, F., Crea, F., & Montone, R. A. (2025). Sex‐Related Differences in the Prognostic Role of Acetylcholine Provocation Testing. Journal of the American Heart Association, 14(5). https://doi.org/10.1161/jaha.124.037942
Vancouver
Rinaldi R, Russo M, Occhipinti G, Laudani C, Torre I, Colucci M, et al. Sex‐Related Differences in the Prognostic Role of Acetylcholine Provocation Testing. Journal of the American Heart Association. 2025;14(5). doi:10.1161/jaha.124.037942
BibTeX
@article{Rinaldi2025,
author = {Rinaldi, Riccardo and Russo, Michele and Occhipinti, Giovanni and Laudani, Claudio and Torre, Ilaria and Colucci, Michele and Gurgoglione, Filippo Luca and Animati, Francesco Maria and Lenkowicz, Jacopo and Tudor, Andrada Mihaela and Liuzzo, Giovanna and Sanna, Tommaso and Leone, Antonio Maria and Niccoli, Giampaolo and Lanza, Gaetano A and Trani, Carlo and Burzotta, Francesco and Crea, Filippo and Montone, Rocco A},
title = {Sex‐Related Differences in the Prognostic Role of Acetylcholine Provocation Testing},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {5},
doi = {10.1161/jaha.124.037942}
}
EUVIMED